
Sponsored Content
Advertisement


Advertisement

Content of this article was sponsored by Arbor Pharmaceuticals, LLC. Copyright 2020. This Managed Healthcare Executive® publication provides key information regarding a review by Faraone, et al, which was originally published in the Journal of the American Academy of Child & Adolescent Psychiatry (doi: 10.1016/j.jaac.2019.06.012). The authors of the original review are Stephen V. Faraone, PhD; Anthony L. Rostain, MD; C. Brendan Montano, MD; Oren Mason, MD; Kevin M. Antshel, PhD; Jeffrey H. Newcorn, MD. Please consult the full published review for complete information.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Prior authorization isn’t shrinking. Its savings are
2
Novo Nordisk launches Awiqli, a once-weekly basal insulin
3
David Chen, Pharm.D., on Kaiser Permanente's biosimilar strategy
4
Once-weekly pemvidutide begins phase 3 trial for MASH
5


